Universities Receive $100 Million for Biomedical Research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 3
Volume 7
Issue 3

LOS ANGELES--California businessman Alfred E. Mann has donated $100 million each to the University of Southern California (USC) and the University of California at Los Angeles (UCLA) to set up institutes for biomedical research.

 LOS ANGELES--California businessman Alfred E. Mann has donated $100 million each to the University of Southern California (USC) and the University of California at Los Angeles (UCLA) to set up institutes for biomedical research.

At USC, the Alfred E. Mann Institute for Biomedical Engineering will be based on the University’s campus in a building that will also house the Department of Biomedical Engineering. USC president Dr. Steven Sample said that the institute would serve as a bridge between the university and the biomedical industry. Mr. Mann said he hopes the new institutes will encourage development of biotechnology companies in the Los Angeles area.

The gift to UCLA is one of the largest donations ever to a public university. The agreement for the UCLA institute is still being developed.

Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content